← Back to Search

Procedure

Fetoscopic Laser Photocoagulation for Twin Placenta Complications

N/A

Waitlist Available

Led By Michael A Belfort, MD

Research Sponsored by Michael A Belfort

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients who are eligible and elect to undergo fetoscopic selective laser photocoagulation for the treatment of complicated monochorionic-diamniotic pregnancies

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediate post-procedure period (from surgery start until surgery finish)

Awards & highlights

Study Summary

This trial is testing a new tool for treating complicated pregnancies safely and effectively.

Who is the study for?

This trial is for pregnant individuals with twins sharing one placenta (monochorionic-diamniotic pregnancies) who choose to undergo a procedure called fetoscopic selective laser photocoagulation to treat complications.Check my eligibility

What is being tested?

The study is testing new types of fetoscopes, which are special telescopes used in surgery on the fetus. The focus is on their safety and effectiveness when treating twin-to-twin transfusion syndrome via laser therapy.See study design

What are the potential side effects?

While specific side effects aren't listed, procedures involving fetoscopes can potentially lead to bleeding, infection, or damage to the amniotic sac or placenta.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am choosing to have laser surgery for my complicated twin pregnancy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediate post-procedure period (from surgery start until surgery finish)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediate post-procedure period (from surgery start until surgery finish)

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediate post-procedure period (from surgery start until surgery finish) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of adverse events

Number of device defects, malfunctions, or failures

Trial Design

1Treatment groups

Experimental Treatment

Group I: Fetoscopes for Selective Laser PhotocoagulationExperimental Treatment1 Intervention

Single arm study. All patients will undergo selective laser photocoagulation with the use of the fetoscopes in this study.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Michael A BelfortLead Sponsor

4 Previous Clinical Trials

205 Total Patients Enrolled

Baylor College of MedicineOTHER

1,001 Previous Clinical Trials

6,001,652 Total Patients Enrolled

Michael A Belfort, MDPrincipal InvestigatorBaylor College of Medicine

1 Previous Clinical Trials

100 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still room for participants in this experiment?

"As stated on clinicaltrials.gov, this trial has stopped recruiting and is no longer enrolling patients. It was initially established on October 1st 2023 before being updated most recently on August 30th of the same year. Despite not actively seeking new participants, there are still 1 other trials that need volunteers at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Safety and Efficacy of Fetoscopes Used in Fetoscopic Selective Laser Photocoagulation

Michael A Belfort 2024. "Safety and Efficacy of Fetoscopes Used in Fetoscopic Selective Laser Photocoagulation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06022510.